Your browser doesn't support javascript.
loading
Communicating about COVID-19 vaccine development and safety.
Thorpe, Alistair; Fagerlin, Angela; Butler, Jorie; Stevens, Vanessa; Drews, Frank A; Shoemaker, Holly; Riddoch, Marian S; Scherer, Laura D.
Affiliation
  • Thorpe A; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Fagerlin A; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Butler J; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
  • Stevens V; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Drews FA; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
  • Shoemaker H; Geriatrics Research, Education, and Clinical Center (GRECC), VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America.
  • Riddoch MS; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
  • Scherer LD; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
PLoS One ; 17(8): e0272426, 2022.
Article de En | MEDLINE | ID: mdl-35930557

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Communication sur la santé / Vaccins contre la COVID-19 / COVID-19 / Développement de vaccin Type d'étude: Clinical_trials / Prognostic_studies / Qualitative_research Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Communication sur la santé / Vaccins contre la COVID-19 / COVID-19 / Développement de vaccin Type d'étude: Clinical_trials / Prognostic_studies / Qualitative_research Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique